Guest: Keith Flaherty, MD

In this presentation, Dr. Keith Flaherty will be discussing how to evaluate the role of immunotherapeutic agents in the treatment of advanced or metastatic melanoma, as well as the potential of these same agents in the adjuvant setting. He will also talk about how to anticipate the onset of immune-related adverse events in patients with melanoma, and their impact on management strategies. This activity was made possible through an educational grant from Merck.